Evidence map›Paper›PMID 26536359›Full record

ArticlePLoS genetics2015

Leaderless Transcripts and Small Proteins Are Common Features of the Mycobacterial Translational Landscape.

Scarlet S Shell, Jing Wang, Pascal Lapierre, Mushtaq Mir, Michael R Chase, Margaret M Pyle, Richa Gawande, Rushdy Ahmad, David A Sarracino, Thomas R Ioerger and 4 more

Abstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed.

  1. Mutations inJAC-antimicrobial resistance · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Recent Characterization of Key Proteins to Combat Tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  16. Regulation of a nickel tolerance operon conserved inApplied and environmental microbiology · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Review

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Scarlet S ShellDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Jing WangWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Pascal LapierreWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Mushtaq MirWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Michael R ChaseDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Margaret M PyleBroad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Richa GawandeDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Rushdy AhmadBroad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
David A SarracinoThermoFisher Scientific BRIMS Center, Cambridge, Massachusetts, United States of America.
Thomas R IoergerDepartment of Computer Science, Texas A&M University, College Station, Texas, United States of America.
Sarah M FortuneDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Keith M DerbyshireWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Joseph T WadeWadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Todd A GrayWadsworth Center, New York State Department of Health, Albany, New York, United States of America.

Funding

The roles of genes critical for growth under defined conditions in vitro or duriU19AI107774 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI CARR, STEVEN A, FORTUNE, SARAH · 2013 to 2017
$13.2M
The Graduate Program in Tropical Infectious Diseases (GPiTID)T32AI049928 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Flaminia Catteruccia, Phyllis J. Kanki · 2001 to 2026
$5.0M
Epidemiology of Infectious Diseases and BiodefenseT32AI007535 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRAD, YONATAN H, MURRAY, MEGAN B · 1998 to 2025
$4.8M
A Community Mycobacterial Systems ResourceR01AI097191 · NIAID · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, FORTUNE, SARAH · 2012 to 2016
$3.2M
Variation in M. tuberculosis in response to host selectionDP2OD001378 · OD · HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2007 to 2009
$2.5M
The regulatory function of DNA methylation in Mycobacterium tuberculosisF32AI085911 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI SHELL, SCARLET SARA · 2010 to 2012
$159k
NIAID NIH HHS 2T32AI049928NIAID NIH HHS 5F32AI085911-02NIAID NIH HHS 5T32AI007535-15NIAID NIH HHS AI097191-01A1NIAID NIH HHS F32 AI085911NIAID NIH HHS R01 AI097191NIAID NIH HHS T32 AI007535NIAID NIH HHS T32 AI049928NIAID NIH HHS U19 AI107774NIH HHS 1DP2OD001378-01NIH HHS DP2 OD001378
6 · The paper itself

Abstract

RNA-seq technologies have provided significant insight into the transcription networks of mycobacteria. However, such studies provide no definitive information on the translational landscape. Here, we use a combination of high-throughput transcriptome and proteome-profiling approaches to more rigorously understand protein expression in two mycobacterial species. RNA-seq and ribosome profiling in Mycobacterium smegmatis, and transcription start site (TSS) mapping and N-terminal peptide mass spectrometry in Mycobacterium tuberculosis, provide complementary, empirical datasets to examine the congruence of transcription and translation in the Mycobacterium genus. We find that nearly one-quarter of mycobacterial transcripts are leaderless, lacking a 5' untranslated region (UTR) and Shine-Dalgarno ribosome-binding site. Our data indicate that leaderless translation is a major feature of mycobacterial genomes and is comparably robust to leadered initiation. Using translational reporters to systematically probe the cis-sequence requirements of leaderless translation initiation in mycobacteria, we find that an ATG or GTG at the mRNA 5' end is both necessary and sufficient. This criterion, together with our ribosome occupancy data, suggests that mycobacteria encode hundreds of small, unannotated proteins at the 5' ends of transcripts. The conservation of small proteins in both mycobacterial species tested suggests that some play important roles in mycobacterial physiology. Our translational-reporter system further indicates that mycobacterial leadered translation initiation requires a Shine Dalgarno site in the 5' UTR and that ATG, GTG, TTG, and ATT codons can robustly initiate translation. Our combined approaches provide the first comprehensive view of mycobacterial gene structures and their non-canonical mechanisms of protein expression.

Indexed as

Genes, BacterialMycobacteriumRibosomesRNA, MessengerSequence Analysis, RNARNA, Messenger

Identifiers

PMID26536359
PMCPMC4633059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.